Hepatitis B Virus (HBV)

Category: Disease

Establishing priorities for national communicable disease surveillance: DISCUSSION

It is vital to emphasize that what is important in this exer­cise is not the absolute number of points given to a disease, but rather the relative position of the disease to others, and the cut-off point chosen. After ranking the scores, the subcom­mittee chose a cut-off of 13 points to recommend a disease for […]

Establishing priorities for national communicable disease surveillance: POTENTIAL TO DRIVE PUBLIC HEALTH POLICY

The definition of ‘potential to drive public health policy’ implies that other criteria of incidence, severity, risk percep­tion and preventability should be considered in determining the potential to drive public health policy. The factor is divided into three levels: ‘low’ with a score of 1; ‘medium’ with a score of 2; and ‘high’ with a […]

Establishing priorities for national communicable disease surveillance: SEVERITY

Severity is defined as ‘most likely outcome’ and classified into three groups. One point is assigned to the disease if it is of short duration and the patient completely recovers. Five points are assigned if the most likely outcome is death; for ex­ample, HIV, AIDS and rabies were each assigned a score of 5. POTENTIAL […]

Establishing priorities for national communicable disease surveillance: INTERNATIONAL CONSIDERATIONS

The World Health Organization (WHO) is interested in all communicable diseases to some extent; however, cholera, plague and yellow fever are subject to international health regulations. Canada must collect and report information about cases of these diseases as an international duty. Five points were awarded to the three diseases. Five points were awarded to measles […]

Establishing priorities for national communicable disease surveillance: part 2

Before 1987, there was no mechanism in place to evaluate newly emerging diseases and compare them with the diseases that were being reported. Accordingly, in 1987, ACE estab­lished a subcommittee on communicable diseases to develop a systematic process to determine which communicable dis­eases should be monitored at the national level. The subcom­mittee asked which diseases […]

Establishing priorities for national communicable disease surveillance

The federal government has collected information on communicable diseases since 1924, under the legisla­tive authority of the Statistics Canada Act and the Health Canada Act. Aggregate data on communicable diseases was initially collected and collated by The Dominion Bureau of Statistics (later changed to Statistics Canada), but this respon­sibility, with the exception of tuberculosis, was […]

The treatment of Paget’s: Available specific therapies part 2

Alendronate. Alendronate is available for the treatment of Paget’s disease in most western countries (Fosamax 40). The recommended dose is 40 mg daily for 6 months to be taken with a large glass of water (>200 ml) on getting up in the morn­ing after an overnight fast. The patient is instructed not to take anything […]

Tags